memantine has been researched along with alpha-aminopyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kelve, M; Müller, WE; Pergande, G; Perovic, S; Schleger, C; Ushijima, H | 1 |
| Rösche, J | 1 |
| Kennard, C; Mehta, AR | 1 |
1 review(s) available for memantine and alpha-aminopyridine
| Article | Year |
|---|---|
The pharmacological treatment of acquired nystagmus.
Topics: Amines; Aminopyridines; Baclofen; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Memantine; Nystagmus, Congenital; Nystagmus, Pathologic; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
2 other study(ies) available for memantine and alpha-aminopyridine
| Article | Year |
|---|---|
Neurotoxicity in rat cortical cells caused by N-methyl-D-aspartate (NMDA) and gp120 of HIV-1: induction and pharmacological intervention.
Topics: Aminopyridines; Animals; Apoptosis; Arachidonic Acid; Cells, Cultured; Cerebral Cortex; Enzyme Inhibitors; HIV Envelope Protein gp120; HIV-1; Memantine; Models, Biological; N-Methylaspartate; Neurons; Neuroprotective Agents; Phospholipases A; Phospholipases A2; Rats | 1996 |
Treatment of spasticity.
Topics: Acetates; Amines; Aminopyridines; Baclofen; Benzodiazepines; Botulinum Toxins, Type A; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Memantine; Muscle Spasticity; Paralysis; Rhizotomy | 2002 |